0.8768
price down icon0.25%   -0.0022
after-market After Hours: .88 0.0032 +0.36%
loading
AEON Biopharma Inc. stock is traded at $0.8768, with a volume of 54,734. It is down -0.25% in the last 24 hours and down -27.54% over the past month. AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed a Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of both chronic and episodic migraine. AEON Biopharma, Inc. is based in Irvine, California.
See More
Previous Close:
$0.879
Open:
$0.88
24h Volume:
54,734
Relative Volume:
0.39
Market Cap:
$34.78M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-10.53%
1M Performance:
-27.54%
6M Performance:
-48.42%
1Y Performance:
-81.66%
1-Day Range:
Value
$0.87
$0.9195
1-Week Range:
Value
$0.87
$0.98
52-Week Range:
Value
$0.636
$17.17

AEON Biopharma Inc. Stock (AEON) Company Profile

Name
Name
AEON Biopharma Inc.
Name
Phone
(949) 354-6499
Name
Address
5 Park Plaza, Suite 1750, Irvine
Name
Employee
9
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
AEON's Discussions on Twitter

AEON Biopharma Inc. Stock (AEON) Latest News

pulisher
Oct 08, 2024

AEON Biopharma Inc. (AEON) Stock: Exploring a Year of Highs, Lows, and Trading Volume - The InvestChronicle

Oct 08, 2024
pulisher
Oct 07, 2024

AEON Biopharma Releases New Investor Presentation - TipRanks

Oct 07, 2024
pulisher
Oct 01, 2024

AEON Biopharma stock earns buy rating, holds price target on FDA meeting - Investing.com

Oct 01, 2024
pulisher
Sep 30, 2024

AEON Biopharma maps FDA path for Botox biosimilar - Investing.com

Sep 30, 2024
pulisher
Sep 30, 2024

AEON receives positive outcome in FDA biosimilar advisory meeting - MSN

Sep 30, 2024
pulisher
Sep 30, 2024

AEON Biopharma Announces Positive Outcome from FDA Biosimilar Advisory Meeting - The Manila Times

Sep 30, 2024
pulisher
Sep 27, 2024

AEON Biopharma (AMEX:AEON) Stock Quotes, Forecast and News Summary - Benzinga

Sep 27, 2024
pulisher
Sep 11, 2024

AEON Biopharma, Inc. (AEON) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - MSN

Sep 11, 2024
pulisher
Sep 02, 2024

Trading Day Triumph: AEON Biopharma Inc. (AEON) Ends at 0.83, a -12.12 Surge/Plunge - The Dwinnex

Sep 02, 2024
pulisher
Aug 19, 2024

AEON Biopharma to Participate in the H.C. Wainwright 26th Annual Global Investment Conference 2024 - ForexTV.com

Aug 19, 2024
pulisher
Aug 17, 2024

HC Wainwright Analysts Raise Earnings Estimates for AEON Biopharma, Inc. (NASDAQ:AEON) - Defense World

Aug 17, 2024
pulisher
Aug 16, 2024

Vanguard Group Inc. Increases Position in AEON Biopharma, Inc. (NASDAQ:AEON) - Defense World

Aug 16, 2024
pulisher
Aug 15, 2024

AEON Biopharma (NASDAQ:AEON) Given New $5.00 Price Target at HC Wainwright - Defense World

Aug 15, 2024
pulisher
Aug 15, 2024

HC Wainwright Weighs in on AEON Biopharma, Inc.’s FY2028 Earnings (NASDAQ:AEON) - Defense World

Aug 15, 2024
pulisher
Aug 14, 2024

H.C. Wainwright sees potential in AEON Biopharma stock despite funding uncertainties - Investing.com Canada

Aug 14, 2024
pulisher
Aug 13, 2024

Midday Stock Roundup: Veritone Soars on NCAA Deal - Orange County Business Journal

Aug 13, 2024
pulisher
Aug 12, 2024

AEON Stock Earnings: AEON Biopharma Beats EPS for Q2 2024 - InvestorPlace

Aug 12, 2024
pulisher
Aug 12, 2024

AEON Biopharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 - Marketscreener.com

Aug 12, 2024
pulisher
Aug 12, 2024

AEON Biopharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update - wallstreet:online

Aug 12, 2024
pulisher
Aug 07, 2024

AEON Biopharma : Corporate Presentation - Marketscreener.com

Aug 07, 2024
pulisher
Aug 07, 2024

AEON Biopharma Inc. (AEON) Stock: From Low to High in 52 Weeks - The InvestChronicle

Aug 07, 2024
pulisher
Aug 06, 2024

AEON Biopharma Releases New Corporate Presentation - TipRanks

Aug 06, 2024
pulisher
Aug 05, 2024

Ratio Analysis: Unpacking AEON Biopharma Inc. (AEON)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex

Aug 05, 2024
pulisher
Aug 01, 2024

AEON Biopharma (NASDAQ:AEON) Shares Down 11.8% - MarketBeat

Aug 01, 2024
pulisher
Aug 01, 2024

Was there any good news for AEON Biopharma Inc. (AEON) stock in the last session? - US Post News

Aug 01, 2024
pulisher
Aug 01, 2024

AEON Biopharma (NASDAQ:AEON) Trading Down 11.8% - Defense World

Aug 01, 2024
pulisher
Jul 30, 2024

The Psychology of AEON Biopharma Inc. Inc. (AEON) Price Performance: Understanding Market Sentiment - The InvestChronicle

Jul 30, 2024
pulisher
Jul 30, 2024

Insider’s View: Deciphering AEON Biopharma Inc. (AEON)’s Financial Health Through Ratios - The Dwinnex

Jul 30, 2024
pulisher
Jul 26, 2024

Midday Stock Roundup: loanDepot Rises on Investor Hopes for Fed - Orange County Business Journal

Jul 26, 2024
pulisher
Jul 26, 2024

Views of Wall Street’s Leading Experts on AEON Biopharma Inc. - SETE News

Jul 26, 2024
pulisher
Jul 22, 2024

How to interpret AEON Biopharma Inc. (AEON)’s stock chart patterns - US Post News

Jul 22, 2024
pulisher
Jul 22, 2024

AEON Biopharma Inc. (AEON) Stock: Navigating Market Highs and Lows in 52 Weeks - The InvestChronicle

Jul 22, 2024
pulisher
Jul 18, 2024

AEON Biopharma Inc.’s Market Journey: Closing Weak at 2.64, Down -7.69 - The Dwinnex

Jul 18, 2024
pulisher
Jul 18, 2024

3 Penny Stocks to Watch Now, 7/18/24 - TipRanks

Jul 18, 2024
pulisher
Jul 17, 2024

A significant driver of top-line growth: AEON Biopharma Inc. (AEON) - SETE News

Jul 17, 2024
pulisher
Jul 16, 2024

Wall Street-Heavily Traded - WDRB

Jul 16, 2024
pulisher
Jul 16, 2024

Why Match Group Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Benzinga

Jul 16, 2024
pulisher
Jul 15, 2024

AEON’s Financial Health: Exploring AEON Biopharma Inc.’s Debt-to-Equity Ratio of 1.79 - The InvestChronicle

Jul 15, 2024
pulisher
Jul 13, 2024

Head to Head Contrast: AEON Biopharma (NASDAQ:AEON) vs. Phibro Animal Health (NASDAQ:PAHC) - Defense World

Jul 13, 2024
pulisher
Jul 12, 2024

AEON Biopharma announces strategic reprioritization for ABP-450 - MSN

Jul 12, 2024

AEON Biopharma Inc. Stock (AEON) Financials Data

There is no financial data for AEON Biopharma Inc. (AEON). Check out other stocks for more information.

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Cap:     |  Volume (24h):